About Us

For Media Inquiries, Please Contact:

Jordan Berman
Vice President,
Global Corporate Communications

Apotex Inc.
  150 Signet Drive,
North York,
ON, M9L 1T9
Canada
   416-401-7487
   Email

Press Center

June 8, 2017

Canadian Scientists Honored for Role in Breakthrough Drug

Two Toronto scientists who spearheaded the research that brought a life-saving drug to patients around the world are being honored at the annual Cooley's Anemia Foundation Gala tonight in New York City.
April 28, 2017

University of Saskatchewan, Apotex renew partnership with $1.6M donation to the College of Pharmacy and Nutrition

The University of Saskatchewan and Apotex Inc. have renewed their partnership with a $1.6 million donation by the company to the College of Pharmacy and Nutrition.
March 8, 2017

Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company's Largest Investment in the United States

Today Apotex Inc., the largest Canadian owned pharmaceutical company, announced the details of a $184 million U.S. expansion plan
March 31, 2016

Launch of Key Biosimilar Medicine To Help Save Healthcare Budgets

Apobiologix^®, a Division of Apotex Inc., today launched Grastofil^®, its first subsequent entry biologic (SEB) approved in Canada.
March 24, 2016

Apotex Launches First Generic Version of Merck's Nasonex®

Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex^® nasal spray (mometasone furoate monohydrate) in the United States.